Colombier Acquisition Corp. II (CLBR) is a special purpose acquisition company (SPAC) focused on identifying and merging with businesses in the technology and healthcare sectors, particularly those demonstrating high growth potential. Established to capitalize on the evolving demand for innovation and advanced solutions, the company aims to leverage its management team's extensive industry experience and strategic network to create value for shareholders. With the ongoing transformation in these sectors, CLBR is positioned to pursue opportunities that can drive substantial returns through operational synergies and market expansion.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.87% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.36 |
| Price-to-Book | 2.13 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 229.10% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $17.25M |
| Float | $11.84M |
| % Insiders | 0.00% |
| % Institutions | 85.59% |